From: Patient medication counselling in community pharmacy: evaluation of the quality and content
Demographic information | Variables | Frequency (%) | Mean ± SD |
---|---|---|---|
Age, years |  |  | 34.54 ± 12.07 |
*Age group (n = 95) | ≤ 25 | 13 (13.7) |  |
26–45 | 68 (71.6) | ||
46–65 | 11 (11.6) | ||
66+ | 3 (3.2) | ||
Gender (n = 120) | Male | 76 (63.3) |  |
Female | 44 (36.7) | ||
Country of pharmaceutical training (n = 121) | Nigeria | 116 (95.9) |  |
Outside Nigeria | 5 (4.1) | Â | |
Cadre of pharmacist (n = 118) | Superintendent pharmacist | 52 (44.1) |  |
NYSC pharmacist | 7 (5.9) | Â | |
Post-intern locum pharmacist | 9 (7.6) | Â | |
Pharmacy manager | 21 (17.8) | Â | |
Staff pharmacist | 29 (24.6) | Â | |
Highest educational qualification (n = 122) | B.Pharm | 94 (77.0) |  |
Pharm. D | 9 (7.4) | Â | |
M.Pharm/M.Sc | 13 (10.7) | Â | |
FPCPharm | 3 (2.5) | Â | |
MBA | 1 (0.8) | Â | |
Ph.D | 2 (1.6) | Â | |
Practiced in other pharmacy setting (n = 120) | Yes | 99 (82.5) |  |
No | 21 (17.5) | Â | |
Previous area of practice (n = 102) | Research/Academia | 4 (3.9) |  |
Hospital | 69 (67.6) | Â | |
Government and NGOs | 3 (2.9) | Â | |
Pharmaceutical industry | 12 (11.8) | Â | |
Sales representative | 13 (12.7) | Â | |
Public health | 1 (1.0) | Â | |
*Years of post-NYSC community practice Group (n = 108) |  |  | 6.33 ± 9.34 |
≤ 5 | 74 (68.5) |  | |
6–17 | 24 (22.2) |  | |
18–29 | 1 (0.9) | ||
30+ | 9 (8.3) | ||
*Years of community pharmacy experience Group (n = 121) |  |  | 6.31 ± 8.69 |
≤ 5 | 84 (69.4) |  | |
6–20 | 29 (24.0) | ||
21–35 | 5 (4.1) | ||
36+ | 3 (2.5) | ||
*Estimated number of prescriptions filled or seen in the pharmacy per day (n = 113) |  |  | 36.80 ± 48.93 |
≤ 50 | 94 (83.2) | ||
51–140 | 16 (14.2) | ||
141–230 | 1 (0.9) | ||
231+ | 2 (1.8) | ||
*Estimated number of PCs attended to per day (n = 116) |  |  | 85.16 ± 129.01 |
≤ 100 | 94 (81.0) |  | |
101–400 | 20 (17.2) | ||
701+ | 2 (1.7) | ||
*Estimated time spent with each pharmacy customer (min) Group (n = 120) |  |  | 8.38 ± 4.87 |
≤ 2 | 5 (4.2) |  | |
3–8 | 59 (49.2) | ||
9–14 | 37 (30.8) | ||
15+ | 19 (15.8) |